| Financial Year |
March 31 2023 |
| Monetary Funds |
619,114,547.64 |
| Held-for-trading Financial Assets |
494,714,900.00 |
| Notes Receivable |
3,138,501.94 |
| Accounts Receivable |
376,771,371.68 |
| Advances to Suppliers |
21,538,899.53 |
| Other Receivables |
44,132,016.14 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
239,389,025.71 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,288,637.05 |
| Total Current Assets |
1,802,087,899.69 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
61,737,265.63 |
| Investment Properties |
-- |
| Fixed Assetes |
415,608,069.07 |
| Under-construction Projects |
9,511,999.74 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
107,245,717.90 |
| R&D expenses |
-- |
| Goodwill |
162,442,800.33 |
| Long-Term Deferred and Prepaid Expenses |
71,629,818.00 |
| Deferred Income Tax Assets |
72,664,305.09 |
| Other Non-Current Assets |
3,687,452.74 |
| Sub-Total of Non-Current Assets |
1,117,969,182.09 |
| Total Assets |
2,920,057,081.78 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,600,000.00 |
| Accounts Payable |
197,409,426.68 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
39,955,724.32 |
| Taxes Payable |
29,361,592.43 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
45,931,495.91 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
41,576,134.69 |
| Other Current Liabilities |
11,540.00 |
| Sub-Total of Current Liabilities |
482,705,020.28 |
| Long-term Loans |
-- |
| Bonds Payable |
577,950,821.02 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
6,898,222.40 |
| Deferred Income Tax Liabilities |
4,195,641.53 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
711,844,843.87 |
| Total Liabilities |
1,194,549,864.15 |
| Paid-In Capital(Or Share Stock) |
624,142,288.00 |
| Capital Surplus |
192,869,454.92 |
| Surplus Reserve |
160,982,636.58 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
519,029,878.40 |
| Minority Stockholder's Interest |
95,667,570.27 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,629,839,647.36 |
| Owner's Equity（Stockholder's Equity） |
1,725,507,217.63 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,920,057,081.78 |
